Grief and Pining Formula

Manufacturer: Feelgood Health | W. Last
Effective date: 2010-09-03
Label type: OTC ANIMAL DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-06-01 02:02:35

Label at a glance#

ProductGrief and Pining Formula

Active ingredientHYPERICUM PERFORATUM, CHAMOMILE, STRYCHNOS IGNATII SEED, AJI PEPPER, POTASSIUM PHOSPHATE

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.877.289.1235

PhoneLabel contact1.561.999.8857

Websitewww.nativeremedies.com

www.nativeremedies.com

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Reduces anxiety during separation and grief after loss

INDICATIONS & USAGE SECTION

Indications: Homeopathic soothing remedy for sadness and separation in pets.

DOSAGE & ADMINISTRATION SECTION

Dosage: If possible, begin treatment a few days before separation to support your pet. Cats and dogs under 20 lbs: Large pinch of granules sprinkled into mouth. Dogs 20-50 lbs: 2 pinches sprinkled into mouth. Dogs over 50 lbs: 1/4 cap of granules sprinkled into mouth. Administer 3-5 times daily or as needed.

GENERAL PRECAUTIONS SECTION

Caution: Consult your vet if symptoms persist or worsen. Keep this and all medicines from the reach of children.

OTC - ACTIVE INGREDIENT SECTION

Ingredients: Each dose contains equal parts of Hypericum (3X) (HPUS), Chamomilla (3X) (HPUS), Ignatia (30C) (HPUS), Capsicum (30C) (HPUS), Kali phos (6C) (HPUS)

INACTIVE INGREDIENT SECTION

Sucrose (inactive ingredient).

WARNINGS SECTION

Contains no gluten, artificial flavors, colors or preservatives.

INFORMATION FOR PATIENTS SECTION

All Native Remedies health products are especially formulated by experts in the field of natural health and are manufactured according to the highest pharmaceutical standards for maximum safety and effectiveness. For more information, visit us at www.nativeremedies.com

Distributed by

Native Remedies, LLC

6531 Park of Commerce Blvd.

Suite 160

Boca Raton, FL 33487

Phone: 1.877.289.1235

International: + 1.561.999.8857

The letters HPUS indicate that the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopoeia of the United States.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

bottle label

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
d9771140-739b-484b-ae64-b79528ff1211	Product name	3	20250801
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68647-150-10	Grief and Pining Formula	20000 mg in 1 BOTTLE, GLASS	GRANULE	20000		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68647-150	GRIEF AND PINING FORMULA (HYPERICUM, CHAMOMILLA, IGNATIA, CAPSICUM, KALI PHOS) GRANULE [FEELGOOD HEALTH]	2	1 package rows	20100913_d2b5d963-1ee3-475d-973d-ba22bc1434d7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
AJI PEPPER	ACTIVE INGREDIENT	2J6IV6A74V	2
CHAMOMILE	ACTIVE INGREDIENT	FGL3685T2X	2
HYPERICUM PERFORATUM	ACTIVE INGREDIENT	XK4IUX8MNB	2
POTASSIUM PHOSPHATE	ACTIVE INGREDIENT	B7862WZ632	2
STRYCHNOS IGNATII SEED	ACTIVE INGREDIENT	1NM3M2487K	2
AJI PEPPER	ACTIVE MOIETY	2J6IV6A74V	2
CHAMOMILE	ACTIVE MOIETY	FGL3685T2X	2
HYPERICUM PERFORATUM	ACTIVE MOIETY	XK4IUX8MNB	2
POTASSIUM CATION	ACTIVE MOIETY	295O53K152	2
STRYCHNOS IGNATII SEED	ACTIVE MOIETY	1NM3M2487K	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Grief and Pining Formula
Hypericum, Chamomilla, Ignatia, Capsicum, Kali phos
HYPERICUM PERFORATUM
CHAMOMILE
STRYCHNOS IGNATII SEED
AJI PEPPER
POTASSIUM PHOSPHATE
POTASSIUM CATION
SUCROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68647-150	68647-150-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
HYPERICUM PERFORATUM	XK4IUX8MNB	ACTIB
CHAMOMILE	FGL3685T2X	ACTIB
STRYCHNOS IGNATII SEED	1NM3M2487K	ACTIB
AJI PEPPER	2J6IV6A74V	ACTIB
POTASSIUM PHOSPHATE	B7862WZ632	ACTIB
SUCROSE	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 22 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hypericum Perforatum 30c	HYPERICUM PERFORATUM	SEVENE USA	ffd205e0-e01c-441d-a9cb-040855b15c17	2026-03-18	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Hypericum Perforatum 200ck	HYPERICUM PERFORATUM	SEVENE USA	cf84ec11-d358-52cb-e053-2995a90ab3af	2026-03-18	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum 7121	HYPERICUM PERFORATUM	Professional Complementary Health Formulas	89553898-20e3-4bbd-a7b3-0a5034c51600	2026-01-08	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85ca53d0-c6d0-ef96-e053-2991aa0a7c34	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85cab607-c6d7-c28e-e053-2a91aa0adf57	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85cab607-c6b6-c28e-e053-2a91aa0adf57	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85caf69a-43ca-816c-e053-2991aa0ac94c	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85c9cdf2-d35d-47cb-e053-2991aa0ab00b	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85ca037f-971a-2224-e053-2991aa0a0d3e	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	7c39a6a0-7b72-11e6-b1b9-424c58303031	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85c9ff86-a62a-1115-e053-2991aa0a580c	2026-01-02		Name fallback generic name: HYPERICUM PERFORATUM
Frankincense and Myrrh Arthritis Pain Therapy	HYPERICUM PERFORATUM	Wise Consumer Products Co.	d3b5d4e1-39ab-f783-e053-2995a90ab2d0	2025-12-31	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85ca8916-5b04-132e-e053-2a91aa0ac56d	2025-12-30	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85cad8e2-1332-9897-e053-2a91aa0abd1e	2025-12-30		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85c9ffa3-a7fa-213e-e053-2a91aa0ae9d2	2025-12-30		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum perforatum	HYPERICUM PERFORATUM	Boiron	85cad8e2-1341-9897-e053-2a91aa0abd1e	2025-12-30		Name fallback generic name: HYPERICUM PERFORATUM
Hypericum Perforatum 30X	HYPERICUM PERFORATUM	Laboratoire Schmidt-Nagel Inc.	3363ee64-2f54-1467-e063-6294a90a2a4d	2025-05-20	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Bestmade Natural Products Hypericum	HYPERICUM PERFORATUM	Bestmade Natural Products	2f99219f-1fb0-1e41-e063-6394a90aa4f0	2025-03-05	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
Hypericum	HYPERICUM PERFORATUM	Energique, Inc	2ef4d9c5-0511-4a7b-9431-314c83a4c945	2024-08-05	Warnings	Name fallback generic name: HYPERICUM PERFORATUM
HYPERICUM PERF	HYPERICUM PERFORATUM	Hyland's Inc.	1a917dd3-e028-4e80-9cae-4e7e3b083ecc	2022-12-19	Warnings	Name fallback generic name: HYPERICUM PERFORATUM

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.